The Secretary of Health and Human Services (HHS) has renewed its determination that a public health emergency exists in light of the continued consequences of the COVID-19 pandemic. The determination has been in place since January 31, 2020 and was set to expire on April 16, 2022. Temporary flexibilities and enforcement discretion put in place by the Food and Drug Administration (FDA) in response to this determination are expected to remain in effect for the duration of the public health emergency.
On April 12, 2022, the Secretary of Health and Human Services (HHS), Xavier Becerra, issued a renewal of the determination that a public health emergency exists in light of the continued consequences of the COVID-19 pandemic.1 The renewed declaration will last for the duration of the emergency or 90 days, and may be further extended by the Secretary. The determination has been in place since January 31, 2020.
In response to the COVID-19 pandemic, the FDA established temporary policies providing flexibility for compliance with some of its regulations. These policies are intended to remain in effect for the duration of the public health emergency, and FDA has stated that it intends to publicly communicate whether extensions to these policies are warranted after the public health emergency has been terminated.
As a reminder, these policies include –
We will continue to monitor FDA’s response to COVID-19. Should you have questions on this or any other matter, please do not hesitate to contact us.
Authored by Elizabeth Fawell, Veronica Colas, and Rachel Buff.
Sanctions Navigator: Russia Sanctions
Are you sure want to delete comment ?
Scan this QR Code to share this content